PCI and diagnostic of cardiovascular diseases require a lot

of information to make the appropriate decisions.

Key challenges are:

  • ACCURACY

    SEE WHAT YOU NEED TO SEE,
    ANY PATIENT ANATOMY, ANY ANGULATION

    • Moving anatomies, obesity, steep angulations can impact visibility of lesions
      and the ability to make diagnosis with confidence.
    • Many factors impact overall X-ray dose levels.
    39 %
  • ACCESS

    SIMPLE PATIENT ACCESS, FROM ANYWHERE, FOR ANY PROCEDURE

    • Ergonomy of your system has to be adapted to you.
    • In-line C-Arm requires rotation of the L-Arm to enable head to groin acquisitions.
    • Detector’s size is key to ensure you can see the whole anatomy, and also reach all necessary angulations to make your diagnosis and treat the lesions.
  • EFFICIENCY

    BECAUSE YOUR TIME IS PRECIOUS 

    • Save time
    • Avoid redundant equipment
    • Optimize reporting

GE TECHNOLOGIES TO MEET THE CHALLENGES

Optimal platforms for cardiovascular procedures

  • PCI ASSIST(2)

    Helps improve Image Quality in challenging conditions, with no impact on X-ray dose.
    Image quality improvement:

    • Up to +85% in moving anatomies3
    • Up to +75% in larger patients3

    Helps enhance stent visibility to help guide the intervention before deploying the stent:

    • Enhanced visibility to help guide the 2nd stent and optimize overlap
    • Helps guide the side branch stent relative to the main branch with StentVesselViz

    In 40% of cases, it helped decide the course of intervention4


    Helps assess stent position:

    • Visualize the homogenous deployment of the stent
    • Visualize the stent position vs. other stents and vs. the vessel geometry: Improve visualization of the relation between the stent and the vessel in 70% of cases4

    > Proximal main branch stent deployment with StentViz
    > Final stent deployment: expansion of the stent, minimal overlap, no geographical miss


    CUSTOMERS VOICES! READ TESTIMONIALS CASE REPORT
  • INNOVASENSE(5)

    Automatic optimization of patient/detector distance to optimize overall procedure dose.
  • DOSE MAP(6)

    Visualization of the distribution of the estimated local cumulated dose throught the exam.

  • DICOM PUSH

    For automatic data transfer: Multi-destination automatic DICOM Push.
    • Eliminate redundant equipment (multiple monitors, keyboards, mouse) with MacLab
    • Entire IT workflow from the HIS to the cathlab
    • PCI hemodynamic report is populated with Mac-Lab data that includes imaging and dose information and can provide an automatic export of the report to the HIS
  • ONE TOUCH QA(7)

    A quick and user-friendly quantification tool.

    • Assessment of lesion length and diameters for stent sizing
    • Facilitates confidence in measurement
  • QFR® INTERFACE(9)

    • Assess the functional severity of a lesion with high accuracy, and without a pressure wire or adenosine with MEDIS QFR®.
    • Extensive clinical evidence published in international literature.
    • Applicable pre-during-as well as post-PCI.
    • Workflow interface with GE IGS imaging system(10).
    MORE ABOUT QFR® MEET THE EXPERTS

Find the right IGS series for your cardiac interventions

Optima™ 3 IGS Series*

EXPLORE

Versatility within your reach
Optima™ IGS 320
Optima™ IGS 330

For Diagnostic & PCI:
PCI & CTO

Features:
  • Detector’s size for increased coverage
  • Touch screen to control from tableside

Innova™ IGS 5

EXPLORE

As flexible as it is powerful
IGS 520
IGS 530
IGS 540

For Diagnostic & PCI:
PCI & CTO
and Structural Heart Procedures:
TAVI I LAAC

Features:
  • PCI ASSIST
  • InnovaSense
  • DoseMap
  • Detector’s size for increased coverage
  • Touch screen to control from tableside
  • QFR®

Innova™ IGS 6

EXPLORE

Biplane image-guided system
IGS 620
IGS 630

For Diagnostic & PCI:
PCI & CTO
and Structural Heart Procedures:
TAVI I LAAC

Features:
  • PCI ASSIST
  • InnovaSense
  • Detector’s size for increased coverage
  • Touch screen to control from tableside
  • DoseMap
  • QFR®

Discovery IGS™ 7

EXPLORE

Free yourself from the rails
IGS 730
IGS 740

For Diagnostic & PCI:
PCI & CTO
and Structural Heart Procedures:
TAVI I LAAC I PVM I Mitral & Tricuspid

Features:
  • PCI ASSIST
  • InnovaSense
  • DoseMap
  • Detector’s size for increased coverage
  • Touch screen to control from tableside
  • QFR®

Discovery IGS™ 7 OR

EXPLORE

Rediscover space and movement
IGS 730 OR
IGS 740 OR

For Diagnostic & PCI:
PCI & CTO
and Structural Heart Procedures:
TAVI I LAAC I PVM I Mitral & Tricuspid

Features:
  • PCI ASSIST
  • InnovaSense
  • Detector’s size for increased coverage
  • Touch screen to control from tableside
  • QFR®

 

Not all products are available in all countries. For more information about products and services that are available in your contry, please contact your GE healthcare sales representative.

Supporting Materials

ASSIST Magazine #3

Download

ASSIST Magazine Image based FFR with QFR®

Download
Watch

Benefits of both QFR® and PCI ASSIST

  1. Obesity and overweight – WHO: http://www.who.int/mediacentre/factsheets/fs311/en/
  2. PCI ASSIST solution includes StentViz and StentVesselViz, features of Interventional X-ray systems Innova IGS 5, Innova IGS 6, Discovery IGS 7 and Discovery IGS 7 OR
  3. Improvement vs. same test without PCI ASSIST. IQ & visibility improvement is measured on Innova IGS 530 with phantoms using various Plexiglas thicknesses, acquisition parameters and the NEMA spoke wheel tool (ref 1), calculating the ratio of the contrast of the moving wires to the background noise level. The amount of IQ improvement related to PCI ASSIST depends on the acquisition parameters, clinical task, patient size, amount of motion in the image, anatomical location, and clinical practice. Ref1: A new tool for benchmarking cardiovascular fluoroscopes; S. Balter, Radiation Protection Dosimetry, Vol. 94, No. 1–2 pp. 161–166 (2001). Applicable to Innova IGS 5 (IGS 520, IGS 530 configurations), Innova IGS 6 and Discovery IGS 7 (IGS 730 configuration)
  4. DOC1683165 - Clinical evidence generation study based on Columbia images. The Statements by GE’s customers described here are based on results that were achieved in the customer’s unique setting. Since there is no ” typical ” hospital and many variables exist e.g. hospital size, case med, there can be no guarantee that other customers will achieve the same results. – Method: Assessment of clinical benefit of StentVesselViz: => - Independent assessment of each sequence by 6 experienced interventional cardiologists; - Assessment done in 2 steps by each reviewer:
    1 - Conventional post-deployment angiogram alone x 11 clinical cases
    2 - Angio + SVV sequence x 11 same clinical cases. Results are based on - Consensus of 5/6 operators
  5. Applicable to Innova IGS 5 (IGS 520 and IGS 530 configurations), Innova IGS 6, Discovery IGS 7 (IGS 730 configuration) and Discovery IGS 7 OR (IGS 730 OR configuration)
  6. Applicable to Innova IGS 5, Innova IGS 6 and Discovery IGS 7
  7. Option sold separately
  8. Effect of StentBoost imaging guided percutaneous coronary intervention on mid-term angiographic and clinical outcomes: www.ncbi.nlm.nih.gov/pubmed/23332899
  9. QFR® Analysis is included in QAngio® XA 3D software. Sold by Medis medical imaging systems bv. It is applicable to Innova IGS 5, Innova IGS 6, Discovery IGS 7 and Discovery IGS 7 OR.
  10. GE IGS imaging systems refer to Innova IGS 5, Innova IGS 6, Discovery IGS 7 and Discovery IGS 7 OR

* IGS 3 series refer to Optima IGS 320 or Optima IGS 330